Skip to content

US · DGX · MEDICAL - DIAGNOSTICS & RESEARCH

Quest Diagnostics Incorporated (DGX) intrinsic value and stock valuation

$258.28as of 2026-11-21 · Mkt cap 26.03B

Data updated · price as of 2026-11-21

OvervaluedIC value is 20–50% below the price. The exact IC value, upside and the fair-value band are available with Pro.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Quest Diagnostics Incorporated DCF and intrinsic value

InvestorsCraft values DGX with the Chepakovich two-stage DCF model — currently rated overvalued. How the model works · Run your own DCF prefilled from DGX’s statements →

Quest Diagnostics Incorporated Graham Number

Graham Number: $114.89d — the price is above the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →

Healthcare · Medical - Diagnostics & Research Secaucus, NJ 07094 questdiagnostics.com

How the business is doing

Fiscal 2011–2025, USD

Revenue
$11B+3.2% 5y CAGRd
20112025
Net income
$992M-7.1% 5y CAGRd
20112025
Free cash flow
$1.36B-3.1% 5y CAGRd
20112025
Total equity
$7.29B+1.1% 5y CAGRd
20112025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2011–2025, USD
20252024202320222021
Revenue$11B$9.87B$9.25B$9.88B$10.8B
Operating income$1.6B$1.35B$1.26B$1.43B$2.38B
Net income$992M$871M$854M$946M$2B
EPSd$8.78M$7.71M$7.56M$8.02M$15.6M
Operating cash flow$1.89B$1.33B$1.27B$1.72B$2.23B
Capital expenditure-$-527M-$-425M-$-408M-$-404M-$-403M
Free cash flow$1.36B$909M$864M$1.31B$1.83B
Total assets$16.2B$16.2B$14B$12.8B$13.6B
Total debt$6.92B$7.09B$5.5B$4.71B$4.77B
Net debt$6.5B$6.54B$4.81B$4.4B$3.9B
Total equity$7.29B$6.9B$6.42B$6.01B$6.56B
Cash and short-term investments$420M$549M$686M$315M$872M
Income statement
20252024202320222021
Revenue$11B$9.87B$9.25B$9.88B$10.8B
Cost of revenue$7.51B$6.63B$6.2B$6.45B$6.58B
Gross profit$3.52B$3.24B$3.07B$3.43B$4.21B
Research and development expenses$0.00$0.00$0.00$0.00$0.00
Selling, general and administrative expenses$1.97B$1.77B$1.62B$1.87B$1.73B
Other expenses-$-47M$128M$192M$131M$101M
Operating expenses$1.92B$1.9B$1.81B$2.01B$1.83B
Cost and expenses$9.43B$8.53B$7.99B$8.46B$8.41B
Interest income$13M$25M$11M$10M$1M
Interest expense$277M$226M$163M$148M$152M
Depreciation and amortization$570M$493M$439M$437M$408M
Ebitda$2.19B$1.89B$1.73B$1.82B$3.16B
Operating income$1.6B$1.35B$1.26B$1.43B$2.38B
Total other income/expenses, net-$-243M-$-152M-$-106M-$-149M$296M
Income before tax$1.36B$1.19B$1.16B$1.28B$2.68B
Income tax expense$314M$273M$248M$264M$597M
Net income$992M$871M$854M$946M$2B
Weighted average shares outstanding$111M$111M$112M$116M$125M
Weighted average diluted shares outstanding$113M$113M$113M$118M$128M
Balance sheet
20252024202320222021
Cash and short-term investments$420M$549M$686M$315M$872M
Net receivables$1.41B$1.3B$1.21B$1.2B$1.44B
Inventory$189M$188M$190M$192M$208M
Total current assets$2.38B$2.39B$2.37B$1.9B$2.74B
Property, plant and equipment, net$2.86B$2.76B$2.42B$2.35B$2.3B
Goodwill and intangible assets$10.6B$10.6B$8.9B$8.31B$8.26B
Long-term investments$136M$123M$135M$132M$141M
Total non-current assets$13.8B$13.8B$11.7B$10.9B$10.9B
Total assets$16.2B$16.2B$14B$12.8B$13.6B
Accounts payable$1.6B$287M$378M$324M$357M
Short-term debt$678M$937M$585M$247M$269M
Deferred revenue$0.00$0.00$0.00$0.00$0.00
Total current liabilities$2.28B$2.17B$1.82B$1.55B$1.75B
Long-term debt$6.24B$6.15B$4.91B$4.47B$4.5B
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$6.66B$7.09B$5.79B$5.28B$5.3B
Capital lease obligations$537M$551M$503M$489M$494M
Total liabilities$8.94B$9.26B$7.6B$6.83B$7.05B
Common stock$2M$2M$2M$2M$2M
Retained earnings$9.99B$9.36B$8.83B$8.29B$7.65B
Accumulated other comprehensive income (loss)-$-27M-$-88M-$-14M-$-21M-$-14M
Total equity$7.29B$6.9B$6.42B$6.01B$6.56B
Total investments$136M$123M$135M$132M$141M
Total debt$6.92B$7.09B$5.5B$4.71B$4.77B
Net debt$6.5B$6.54B$4.81B$4.4B$3.9B
Cash flow statement
20252024202320222021
Net income$1.05B$921M$908M$1.02B$2.08B
Depreciation and amortization$570M$493M$439M$437M$408M
Stock-based compensation$88M$88M$77M$77M$79M
Change in working capital$50M-$-201M-$-145M$119M$87M
Accounts receivable-$-106M-$-71M-$-15M$246M$81M
Inventory$0.00$0.00$0.00$0.00-$-20M
Accounts payable$129M-$-67M-$-55M-$-149M$35M
Net cash provided by operating activities$1.89B$1.33B$1.27B$1.72B$2.23B
Investments in property, plant and equipment-$-527M-$-425M-$-408M-$-404M-$-403M
Acquisitions, net-$-101M-$-2.16B-$-611M-$-144M$424M
Net cash used for investing activities-$-631M-$-2.55B-$-1.06B-$-543M$21M
Common stock issued$79M$0.00$0.00$0.00$0.00
Common stock repurchased-$-450M-$-151M-$-275M-$-1.41B-$-2.2B
Dividends paid-$-353M-$-331M-$-314M-$-305M-$-309M
Net cash used for financing activities-$-1.39B$1.08B$160M-$-1.73B-$-2.54B
Net change in cash-$-129M-$-137M$371M-$-557M-$-286M
Cash at end of period$420M$549M$686M$315M$872M
Operating cash flow$1.89B$1.33B$1.27B$1.72B$2.23B
Capital expenditure-$-527M-$-425M-$-408M-$-404M-$-403M
Free cash flow$1.36B$909M$864M$1.31B$1.83B
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Quest Diagnostics Incorporated

        Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.

        CEO
        James E. Davis
        Employees
        57K
        Beta
        0.57

        Included in

        Explore

        Frequently asked questions

        What is the intrinsic value of Quest Diagnostics Incorporated (DGX)?

        Quest Diagnostics Incorporated (DGX) is currently overvalued based on the InvestorsCraft IC model — IC value is 20–50% below the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.

        Is DGX undervalued?

        DGX trades at a price of $258.28 (Nov 21, 2026): overvalued — IC value is 20–50% below the price.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.